↓ Skip to main content

Dove Medical Press

Increased risk of pernicious anemia following scabies: a nationwide population-based matched-cohort study

Overview of attention for article published in Therapeutics and Clinical Risk Management, September 2017
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users
facebook
1 Facebook page

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
21 Mendeley
Title
Increased risk of pernicious anemia following scabies: a nationwide population-based matched-cohort study
Published in
Therapeutics and Clinical Risk Management, September 2017
DOI 10.2147/tcrm.s137662
Pubmed ID
Authors

Jui-Ming Liu, Ren-Jun Hsu, Fung-Wei Chang, Feng-Hsiang Chiu, Chia-Lun Yeh, Chun-Fa Huang, Shu-Ting Chang, Hung-Chang Lee, Hsin Chi, Chien-Yu Lin

Abstract

Scabies is a common and annoying disorder. Pernicious anemia (PA) is a serious disease which, when untreated, leads to death. Mounting evidence suggests that immune-mediated inflammatory processes play a role in the pathophysiology of both diseases. The relationship between these two diseases has not been investigated. We conducted this study to explore the potential relationship between scabies and PA. This nationwide, population-based study was conducted using the National Health Insurance Research Database of Taiwan. In total, 5,407 patients with scabies were identified as a study group and 20,089 matched patients were randomly selected as a control group. We tracked patients in both groups for a 7-year period to identify the incidence of PA. The demographic characteristics and comorbidities of the patients were analyzed, and Cox proportional hazards regression was used to calculate the hazard ratios for PA. Of the 25,496 patients in this study, 183 (0.7%) patients with newly diagnosed PA were identified during the 7-year follow-up period; 71 of 5,407 (1.3%) from the scabies group and 112 of 20,089 (0.6%) from the control group. Patients with scabies had a higher risk of subsequent PA, with a crude hazard ratio of 2.368. After adjusting for covariates, the adjusted hazard ratio was 1.51 (95% confidence interval: 1.09-2.08). This study demonstrated an increased risk of PA (adjusted hazard ratio 1.51) among patients with scabies. Immune-mediated inflammatory processes may contribute to this association. Further studies are warranted to investigate the entire pathological mechanisms between these two diseases. Physicians should pay attention to patients with history of scabies presented with anemia. Further confirmative tests of PA may contribute to correct diagnosis and initiation of vitamin B12 supplement.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 21 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 24%
Other 4 19%
Student > Bachelor 1 5%
Student > Ph. D. Student 1 5%
Student > Postgraduate 1 5%
Other 0 0%
Unknown 9 43%
Readers by discipline Count As %
Medicine and Dentistry 5 24%
Biochemistry, Genetics and Molecular Biology 2 10%
Environmental Science 1 5%
Social Sciences 1 5%
Neuroscience 1 5%
Other 0 0%
Unknown 11 52%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 September 2017.
All research outputs
#16,868,837
of 25,584,565 outputs
Outputs from Therapeutics and Clinical Risk Management
#776
of 1,308 outputs
Outputs of similar age
#197,085
of 324,978 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#18
of 29 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,308 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.8. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 324,978 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.